跳至主要内容
临床试验/NCT00416221
NCT00416221已完成不适用

Development and a Pilot Study of the PACEPRO Exercise and Mood Management Program in Depressed Patients on Escitalopram Oxalate (Lexapro)

University of California, San Diego2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2006年4月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Measurement visits will be conducted at the PACE office. The specific activities to be conducted at the baseline, 6 and 12 week assessment visits are listed below.

研究概览

简要总结

Researchers at the University of California at San Diego (UCSD) are conducting a 12-week study to test the PACEPRO program. This program is designed to reduce depression by providing:

Lexapro, an antidepressant medicine...Learn More Physical activity information and pedometer Mood management skills and a Mood Mastery Guide Personalized support from a Family Nurse Practitioner

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have been diagnosed with mild to moderate depression
  • Are willing to take the antidepressant Lexapro
  • Can access and use Email and the Internet
  • Are willing and able to be physically active
  • Access to a primary care physician

排除标准

  • Subjects will be excluded from participation for the following reasons:
  • Pregnancy or breastfeeding
  • Narrow angle glaucoma
  • Any uncontrolled medical condition or any medical condition which would represent a contraindication to Escitalopram Oxalate Lexapro® pharmacotherapy. Any concomitant non-psychotropic medications that the physician determines are a contraindication to Escitalopram Oxalate Lexapro® pharmacotherapy Bipolar disorder, or any psychotic or organic mental disorder or dementia
  • History of intolerance or allergy to Lexapro, or of prior failed treatment for depression with Lexapro
  • Current substance abuse or dependency
  • Current active suicidal ideation
  • Current use of herbal psychoactive treatments such as St. John's Wort
  • Concurrent psychotropic medication is not permitted for 2 weeks prior to randomization (4 weeks in the case of fluoxetine) or at any point after
  • Receipt of formal psychotherapy concurrently
  • Inability, in the investigator's opinion, to comply with study procedures or assessments
  • Inability to exercise

结局指标

主要结局

Measurement visits will be conducted at the PACE office. The specific activities to be conducted at the baseline, 6 and 12 week assessment visits are listed below.

Physiological Measures

时间窗: baseline, 6 weeks, 12 weeks

Height and weight

时间窗: baseline, 6 weeks, 12 weeks

Waist & hip, circumference

时间窗: baseline, 6 weeks, 12 weeks

Blood pressure and pulse

时间窗: baseline, 6 weeks, 12 weeks

Physical activity level measured by wearing a monitor around the waist for 3 days (at baseline and 12 weeks only)

时间窗: baseline, 6 weeks, 12 weeks

Interview/Survey Measures

时间窗: baseline, 6 weeks, 12 weeks

Self report depressive symptoms

时间窗: baseline, 6 weeks, 12 weeks

Self-report of moderate and vigorous physical activity for seven days

时间窗: baseline, 6 weeks, 12 weeks

Self-report of TV viewing and recreational computer use for seven days

时间窗: baseline, 6 weeks, 12 weeks

Self-report on readiness to make changes in physical activity and mood management behaviors

时间窗: baseline, 6 weeks, 12 weeks

Personal assessment of factors related to behavior change including: self-efficacy, social support, barriers to change, and use of behavior change skills, and the environment

时间窗: baseline, 6 weeks, 12 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验